{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:22:31Z","timestamp":1790011351475,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0224686","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T13:44:41Z","timestamp":1573134281000},"page":"e0224686","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1400-3670","authenticated-orcid":true,"given":"Lauren","family":"Dayton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6385","authenticated-orcid":true,"given":"Rachel E.","family":"Gicquelais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Davey-Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun","family":"Falade-Nwulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abenaa A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"pone.0224686.ref001","first-page":"1419","article-title":"Drug and Opioid-Involved Overdose Deaths\u2014United States, 2013\u20132017","volume":"67","author":"S Scholl","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0224686.ref002","unstructured":"Centers for Disease Control and Prevention. Underlying Cause of Death 1999\u20132017 on CDC WONDER Online Database, released December, 2018. 2018."},{"key":"pone.0224686.ref003","author":"National Safety Council","year":"2017","journal-title":"NSC Motor Vehicle Fatality Estimates"},{"key":"pone.0224686.ref004","article-title":"2018 Annual Surveillance Report of Drug-Related Risks and Outcomes\u2014United States","author":"Centers for Disease Control and Prevention","year":"2018","journal-title":"Surveill Spec Rep"},{"key":"pone.0224686.ref005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"P Armenian","year":"2018","journal-title":"Neuropharmacology"},{"issue":"24","key":"pone.0224686.ref006","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2146\/ajhp130798","article-title":"Intranasal naloxone administration for treatment of opioid overdose","volume":"71","author":"A Robinson","year":"2014","journal-title":"Am J Heal Pharm"},{"key":"pone.0224686.ref007","author":"World Health Organization","year":"2014","journal-title":"Substance use: Community management of opioid overdose"},{"issue":"3","key":"pone.0224686.ref008","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/08897077.2018.1439801","article-title":"The relationship between drug use settings, roles in the drug economy, and witnessing a drug overdose in Baltimore, Maryland","volume":"39","author":"CA Latkin","year":"2018","journal-title":"Subst Abus"},{"issue":"11","key":"pone.0224686.ref009","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature","volume":"105","author":"SS Martins","year":"2015","journal-title":"Am J Public Health"},{"issue":"6","key":"pone.0224686.ref010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0955-3959(00)00070-0","article-title":"Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation","volume":"11","author":"J Strang","year":"2000","journal-title":"Int J Drug Policy"},{"key":"pone.0224686.ref011","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugpo.2017.12.020","article-title":"Pharmaceutical opioid overdose deaths and the presence of witnesses","volume":"55","author":"RP Ogeil","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"Suppl 1","key":"pone.0224686.ref012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jlme.12208","article-title":"Lessons Learned from the Expansion of Naloxone Access in Massachusetts and North Carolina","volume":"43","author":"CS Davis","year":"2015","journal-title":"J Law, Med Ethics"},{"issue":"7894","key":"pone.0224686.ref013","first-page":"1","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis","volume":"346","author":"A Walley","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"pone.0224686.ref014","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"R McDonald","year":"2016","journal-title":"Addiction"},{"key":"pone.0224686.ref015","author":"Baltimore City Health Department","year":"2017","journal-title":"Baltimore city health commissioner signs new standing order for opioid overdose reversal medication"},{"issue":"3","key":"pone.0224686.ref016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1360-0443.2005.00975.x","article-title":"Calling emergency medical services during drug overdose: An examination of individual, social and setting correlates","volume":"100","author":"KE Tobin","year":"2005","journal-title":"Addiction"},{"key":"pone.0224686.ref017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","article-title":"\u2018I have it just in case\u2019\u2014Naloxone access and changes in opioid use behaviours","volume":"51","author":"S Heavey","year":"2018","journal-title":"Int J Drug Policy"},{"key":"pone.0224686.ref018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.10.008","article-title":"Factors associated with naloxone administration in an opioid dependent sample","volume":"84","author":"SR Kenney","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"pone.0224686.ref019","first-page":"149","article-title":"Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina","volume":"79","author":"P Khatiwoda","year":"2018","journal-title":"N C Med J"},{"issue":"1","key":"pone.0224686.ref020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00063110-200402000-00004","article-title":"Adverse events after naloxone treatment of episodes of suspected acute opioid overdose","volume":"11","author":"I Buajordet","year":"2004","journal-title":"Eur J Emerg Med"},{"issue":"9","key":"pone.0224686.ref021","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/emj.2003.009613","article-title":"Naloxone in opioid poisoning: Walking the tightrope","volume":"22","author":"SFJ Clarke","year":"2005","journal-title":"Emerg Med J"},{"key":"pone.0224686.ref022","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/106002809202600211","article-title":"Naloxone-associated patient violence:An overlooked toxicity?","volume":"26","author":"G Gladdis","year":"1992","journal-title":"Ann Pharmacother"},{"key":"pone.0224686.ref023","volume-title":"Stata Statistical Software: Release 14","author":"StataCorp","year":"2014"},{"key":"pone.0224686.ref024","author":"Drug Enforcement Administration: Strategic Intelligence Section","year":"2018","journal-title":"Fentanyl Remains the Most Significant Synthetic Opioid Threat and Poses the Greatest Threat to the Opioid User Market in the United States"},{"issue":"0","key":"pone.0224686.ref025","first-page":"1","article-title":"Fentanyl and Drug Overdose: Perceptions of Fentanyl Risk, Overdose Risk Behaviors, and Opportunities for Intervention among People who use Opioids in Baltimore, USA","volume":"0","author":"CA Latkin","year":"2019","journal-title":"Subst Use Misuse"},{"issue":"4","key":"pone.0224686.ref026","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00174059","article-title":"Aggression during morphine withdrawal: Effects of method of withdrawal, fighting experience, and social role","volume":"90","author":"KM Kantak","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"pone.0224686.ref027","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1037\/0735-7028.39.4.396","article-title":"Creating trauma-informed systems: Child welfare, education, first responders, health care, juvenile justice","volume":"39","author":"S Ko","year":"2008","journal-title":"Prof Psychol Res Pract"},{"key":"pone.0224686.ref028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/inm.12012","article-title":"Trauma-informed care in inpatient mental health settings: A review of the literature","volume":"23","author":"C Muskett","year":"2014","journal-title":"Int J Ment Health Nurs"},{"issue":"1","key":"pone.0224686.ref029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06550.x","article-title":"Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose","volume":"182","author":"K Kelly","year":"2005","journal-title":"Med J Aust"},{"issue":"10","key":"pone.0224686.ref030","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/add.13027","article-title":"Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","volume":"110","author":"J Neale","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"pone.0224686.ref031","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2006.pto_233.x","article-title":"Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients","volume":"98","author":"E Rook","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"pone.0224686.ref032","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.drugalcdep.2016.12.003","article-title":"Randomized controlled trial of a computerized opioid overdose education intervention","volume":"173","author":"K Dunn","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"pone.0224686.ref033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugalcdep.2017.07.018","article-title":"Trends in heroin and pharmaceutical opioid overdose deaths in Australia","volume":"179","author":"A Roxburgh","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"pone.0224686.ref034","doi-asserted-by":"crossref","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The Burden of Opioid-Related Mortality in the United States","volume":"1","author":"T Gomes","year":"2018","journal-title":"JAMA Netw Open"},{"key":"pone.0224686.ref035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ypmed.2017.11.001","article-title":"The \u2018fentanyl epidemic\u2019 in Canada\u2013Some cautionary observations focusing on opioid-related mortality","volume":"107","author":"B Fischer","year":"2018","journal-title":"Prev Med (Baltim)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T13:44:57Z","timestamp":1573134297000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0224686"}},"subtitle":[],"editor":[{"given":"Bronwyn","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0224686","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]}}}